{
    "clinical_study": {
        "@rank": "138074", 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if megestrol acetate is safe and effective in treating\n      HIV-infected children with failure to thrive (FTT)."
        }, 
        "brief_title": "A Study of Megestrol Acetate in HIV-Infected Children", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Failure to Thrive"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study design is randomized, double-blind, placebo-controlled for 12 weeks with\n      open-label drug offered after week 12."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Documented HIV infection.\n\n          -  Failure to thrive as defined by:\n\n          -  crossing 2 percentile lines on standard weight for age curves over time or less than\n             5% percentile weight for age and falling from the curve or loss of 10% of baseline\n             body weight.\n\n          -  Resistant to oral nutritional supplementation (i.e., FTT despite a minimum 1-month\n             trial of high-calorie oral supplements).\n\n          -  Free of significant acute illness (mild upper respiratory tract infections allowed).\n\n          -  Patients with chronic diarrhea allowed provided malabsorption and gastrointestinal\n             infection ruled out.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms are excluded:\n\n          -  Gastrointestinal infection or malabsorption.\n\n          -  Significant acute illness.\n\n          -  Any identified, untreated cause for failure to thrive other than underlying HIV\n             infection.\n\n          -  Medical contraindications to megestrol acetate.\n\n        Patients with any of the following prior conditions or symptoms are excluded:\n\n        Medical contraindications to megestrol acetate including a history of poorly-controlled\n        hypertension, deep venous thrombosis, or heart failure.\n\n        History of prior megestrol acetate therapy in the past six months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": "25", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002182", 
            "org_study_id": "266A", 
            "secondary_id": "Gamma 005"
        }, 
        "intervention": {
            "intervention_name": "Megestrol acetate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Megestrol", 
                "Megestrol Acetate", 
                "Appetite Stimulants"
            ]
        }, 
        "keyword": [
            "Placebos", 
            "Appetite Stimulants", 
            "Megestrol Acetate", 
            "Failure to Thrive"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "San Juan", 
                    "country": "Puerto Rico", 
                    "zip": "00936"
                }, 
                "name": "Univ of Puerto Rico / Med Science Campus"
            }
        }, 
        "location_countries": {
            "country": "Puerto Rico"
        }, 
        "official_title": "Megestrol Acetate For Failure To Thrive In Pediatric HIV", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002182"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gamma Project - ACTU", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 1998"
    }, 
    "geocoordinates": {
        "Univ of Puerto Rico / Med Science Campus": "18.466 -66.106"
    }
}